Winslow E, Marshall R J, Campbell J K, Muir A W
J Cardiovasc Pharmacol. 1987 Mar;9(3):257-66. doi: 10.1097/00005344-198703000-00001.
The antiarrhythmic efficacies of intravenous quinidine (Q), disopyramide (D), prenylamine (P), bepridil (B), and practolol were compared in normokalaemic and dietary-induced hypokalaemic anaesthetised rats. Hypokalaemia markedly increased the severity of arrhythmias induced by coronary artery ligation and reduced the antiarrhythmic efficacy of all five drugs tested. After anaesthesia, hypokalaemia was associated with hypotension and bradycardia but not QTc prolongation. However, bradycardia was not seen in conscious hypokalaemic animals. Papillary muscles taken from hypokalaemic rats displayed a longer action potential duration but no increase in Vmax compared with tissue taken from normokalaemic animals. It is concluded that hypokalaemia in the rat causes electrophysiological disturbances which may contribute both to the observed exacerbation of ischaemia-induced arrhythmias and to the reduced efficacy of Q, D, P, and B. The reduced efficacy of practolol might be explained by other consequences of hypokalaemia.
在正常血钾和饮食诱导的低钾血症麻醉大鼠中,比较了静脉注射奎尼丁(Q)、丙吡胺(D)、普尼拉明(P)、苄普地尔(B)和美托洛尔的抗心律失常疗效。低钾血症显著增加了冠状动脉结扎诱导的心律失常的严重程度,并降低了所测试的所有五种药物的抗心律失常疗效。麻醉后,低钾血症与低血压和心动过缓有关,但与QTc延长无关。然而,在清醒的低钾血症动物中未见心动过缓。与正常血钾动物的组织相比,取自低钾血症大鼠的乳头肌显示出更长的动作电位持续时间,但Vmax没有增加。得出的结论是,大鼠低钾血症会引起电生理紊乱,这可能导致观察到的缺血性心律失常加重以及Q、D、P和B疗效降低。美托洛尔疗效降低可能由低钾血症的其他后果来解释。